[Challenges and advances in paediatric arterial ischaemic stroke]
Related Experiment Video
Updated: Jun 26, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Julie Brix Bindslev1, Thomas Truelsen, Mette Gyhrs
1jbbindslev@gmail.com.
Insights
Pediatric arterial ischemic stroke affects over half of children, often with delayed diagnosis. Implementing a systematic pathway can improve recognition and treatment for better outcomes in childhood stroke.
Area of Science:
- Pediatric Neurology
- Neurovascular Diseases
- Stroke Medicine
Background:
- Neurological sequelae affect over 50% of children diagnosed with arterial ischemic stroke (AIS).
- Current diagnostic timelines for pediatric stroke frequently exceed 24 hours, delaying critical interventions.
- Access to hyperacute recanalisation therapies remains limited in the pediatric population.
Purpose of the Study:
- To review clinical presentations, risk factors, and treatment strategies for pediatric ischemic stroke.
- To present the experience and outcomes of a systematic pediatric stroke pathway implemented in Eastern Denmark since 2017.
Main Methods:
- Systematic review of clinical presentations, risk factors, and treatments for pediatric ischemic stroke.
- Description of a implemented systematic pediatric stroke pathway in Eastern Denmark.
Main Results:
- Neurological sequelae are prevalent in over 50% of pediatric AIS cases.
- Diagnostic delays are common, exceeding 24 hours in many instances.
- The implemented pathway aims to expedite recognition and treatment.
Conclusions:
- Early recognition and prompt treatment are crucial for improving outcomes in pediatric stroke.
- Systematic pathways are essential for optimizing the management of childhood arterial ischemic stroke.
- The Danish pathway demonstrates a structured approach to enhancing pediatric stroke care.
Abstract:
Neurological sequelae occur in more than 50% of children with arterial ischemic stroke. Early recognition and treatment are essential in improving outcome. However, diagnostic delay in paediatric stroke often extends beyond 24 hours, and children rarely access hyperacute recanalisation therapies. This review describes clinical presentations, risk factors and treatment of paediatric ischaemic stroke. Additionally, we share our experience from a systematic paediatric stroke pathway implemented in Eastern Denmark since 2017.
More Related Videos
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

